My Payday Loan My Payday Loan

Calendar

June 2013
M T W T F S S
« May    
 12
3456789
10111213141516
17181920212223
24252627282930

Generic Drug News: FDA Approves First Generic Version of Lexapro

HUGE generic drug approval bulletin today. If you have a family member or other loved who suffers from depression or anxiety, the U.S. Food and Drug Administration has approved the first generic versions of the very popular Lexapro (escitalopram oxalate) which treats depression and anxiety.

According to the the National Institute for Health, depression may be described as feeling sad, blue, unhappy, miserable, or down in the dumps. Although most of us feel this way at one time or another for short periods, true clinical depression is a mood disorder in which feelings of sadness, loss, anger, or frustration interfere with everyday life for weeks or longer. People with anxiety disorder worry excessively and have difficulty concentrating, according to the FDA.

Considering a thirty-day supply of brand-name Lexapro is currently running almost $150, this could easily be a huge savings for many depression and anxiety patients, so anyone with a family member or loved one on Lexapro should ask their doctor if they are an appropriate candidate for the generic version of Lexapro.

Do you or a loved one use Lexapro to treat depression and/or anxiety? Tell us about it in our discussion forums!

Join the forum discussion on this post

Related posts:

  1. Generic Drug News: FDA Approves First Generic Version of Zyprexa For Schizophrenia and Bipolar
  2. Generic Drug Questions: When Will Generic Lexapro Be Available in the U.S.?
  3. Quick Generic Drug News: FDA Approves Generic Version of Anti-Epileptic Drug Keppra XR
  4. Lexapro Goes Generic in a Week! What You Need to Know
  5. Generic Drug News: FDA Approves Mylan’s Version of Keppra XR for Epileptic Seizures

Leave a Reply

  

  

  

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>